Skip to main content

Funding

09/30/10 - 09/29/15
NIAID/NIH
Influenza Vaccine Biomanufacturing Training

03/01/2016 - 09/30/2016
NIAID/NIH
Zika Antiviral Screening Assays

09/30/2015 - 09/29/2016
NIAID/NIH
Comprehensive Viral Screening Panel

07/20/2015 - 07/19/2016
NIAID/NIH
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses

10/01/2014 - 09/30/2015
NIAID/NIH
Supplement to Comprehensive Panel for Viruses

09/01/2014 - 08/31/2015
NIAID/NIH
Ebola Replicon Screen

10/01/2014 - 09/30/2015
NIAID/NIH
Ebola, Enterovirus-68 and Enterovirus-71 Screens

09/01/2014 - 08/30/2015
NIAID/NIH
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses

10/01/2014 - 9/30/2015
NIAID/NIH
Comprehensive Panel for Viruses

09/01/2013 - 08/31/2014
NIAID/NIH
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses

10/01/2013 - 09/30/2014
NIAID/NIH
Comprehensive Panel for Viruses

10/01/2011 - 09/30/2012
NIAID/NIH
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses

10/01/2011 - 09/30/2012
NIAID/NIH
Comprehensive Panel for Viruses

10/01/2011 - 11/30/2012
NIAID/NIH
Comprehensive Viruses Panel 2

10/01/2011 - 09/30/2012
NIAID/NIH
Respiratory Panel for Viruses

10/01/2011 - 09/30/2012
NIAID/NIH
In Vitro Assessment for Antimicrobial Activity

01/11/2016 - 01/10/2017
NIAID/NIH
Small Animal Models for Biodefense Viruses

09/15/2015 - 0914/2016
NIAID/NIH
Mouse Models for Evaluation of Influenza Vaccines and Vaccination Strategies

09/15/2015 - 9/14/2016
NIAID/NIH
Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential

08/30/2015 - 08/29/2017
NIAID/NIH
Mouse Model Development of Enteroviruses EV-D68 and EV-71 for Therapeutics

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Orthopoxviruses

09/15/2013 - 03/14/2015
NIAID/NIH
Mouse Models of Medical Countermeasures Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Orthopoxviruses

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Low Pathogenic Seasonal and Pandemic Influenza Viruses for Therapeutics

09/09/2013 - 09/08/2014
NIAID/NIH
Mouse Models for Orthopoxviruses

01/19/2011 - 01/18/2016
NIAID/NIH
Small Animal Models for Biodefense Viruses and Prions

09/27/2010 - 09/26/2015
NIAID/NIH
Human Hepatitis B Virus (HBV) Mouse Models for Testing HBV Therapeutics

09/27/2010 - 09/26/2015
NIAID/NIH
Mouse Models for Evaluation of Influenza Vaccines and Adjuvants

03/01/2016 - 07/31/2017
NIAID/NIH
Zika Virus Intrauterine Infection

08/01/2015 - 07/31/2016
NIAID/NIH
Targeting Induction of Cystosolic Calcium buffers for Treatment of Viral Encephalitis

05/01/2009 - 04/30/2014
Rocky Mountain RCE/NIAID/NIH
T-705 Pyrazine Derivative Treatment of Highly Pathogenic Arenaviral Infections

05/01/2009 - 04/30/2014
Rocky Mountain RCE/NIAID/NIH
Treatment of Acute West Nile Virus Disease and Neurological Sequelae

07/01/2012 - 6/30/2014
NIAID/NIH
Robust, Defined, Animal-Free Cell Culture Medium for the Production of Vaccines

07/01/2015 - 06/30/2016
NIAID/NIH
Identifying Deficits in Brainstem Respiratory Circuits During viral Encephalitis

05/01/2015 - 04/30/2016
NIAID/NIH
Cellular Mechanisms of Fatal Respiratory Insuffieciency in Arboviral Encephalitis

06/01/2012 - 05/31/2014
NIAID/NIH
Targeting Induction of Cytosolic Calcium Buffers for Treatment of Viral Encephalitis